Search clinical trials for: Stalevo

Total 15 results

Orion Corporation, Orion Pharma

Completed

Study to Evaluate Initiation of Stalevo in Early Wearing-off (SENSE)

Parkinson's Disease

Germany, Sweden, United Kingdom
Orion Corporation, Orion Pharma

Completed

Levodopa Concentration Profile With Stalevo 75/125 mg (NEWSTA)

Parkinson's Disease

Finland
Orion Corporation, Orion Pharma

Completed

Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Motor Fluctuations (PARPOC)

Parkinson's Disease
Asan Medical Center

Unknown

Clock and Narcolepsy Genetic Variants and the Effects of Stalevo® (Levodopa/Carbidopa/Entacapone) on Sleep Disorders in Parkinson's Disease

Parkinson Disease | Sleep Disorders

Korea, Republic of
Second Affiliated Hospital of Soochow University

Recruiting

Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's Disease

Parkinson Disease

China
Orion Corporation, Orion Pharma

Completed

Stalevo in Early Wearing-Off Patients (SEWOP)

Idiopathic Parkinson's Disease

United Kingdom, Denmark, Ireland, Finland, Germany, Sweden
Second Affiliated Hospital, School of Medicine,...

Recruiting

Clinical Study of Stalevo in the Treatment of Early Parkinson's Disease

Parkinson Disease

China
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study in Healthy Volunteers (NOCOFPK2)

Parkinson's Disease

Finland
Molecular NeuroImaging

Completed

An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)

Parkinson's Disease
Novartis Pharmaceuticals

Withdrawn

Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off

Parkinson's Disease
Orion Corporation, Orion Pharma

Completed

Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC) (COMPOC)

Parkinson's Disease

Finland, Germany, Hungary, Latvia
Novartis

Completed

A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa

Parkinson's Disease

United States, Canada, Czechia, Israel, Italy, Poland, Portugal, Turkey
Novartis Pharmaceuticals
Orion Corporation, Orion Pharma

Completed

Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy (STRIDE-PD)

Parkinson's Disease

United States, Switzerland, Germany, Finland, Greece, Italy, Spain, United Kingdom, Canada, France, Turkey, Belgium, Sweden, Austria
Novartis

Terminated

Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off

Parkinson's Disease

United States
Otto Bock Healthcare Products GmbH

Completed

Feasibility Study to Evaluate a New Energy Storage and Return Prosthetic Foot

Lower Limb Amputation Below Knee (Injury) | Lower Limb Amputation Above Knee (Injury) | Lower Limb Amputation Knee

United States

3

Subscribe